Loading...
•
Jun 30
Precipio Q2 2025 Earnings Report
Precipio reported revenue growth of 27% YoY and significantly narrowed its adjusted EBITDA loss in Q2 2025.
Key Takeaways
Precipio achieved $5.7 million in revenue in Q2 2025, driven by growth in both product and pathology divisions. The company posted net income of $100,000 and continued improving operational performance, reflected in an 87% YoY improvement in adjusted EBITDA.
Revenue reached $5.7 million, up 27% YoY.
Net income was $100,000, reversing a $1.2 million loss in Q2 2024.
Adjusted EBITDA improved to -$100,000 from -$600,000 YoY.
Cash used in operations dropped 71% to $148,000.
Precipio
Precipio
Forward Guidance
Precipio expects continued revenue and margin growth and aims to be cash flow positive and debt-free by year-end.
Positive Outlook
- Pathology and product divisions both showed revenue growth.
- Gross margin improved YoY from 39% to 43%.
- Company expects to complete debt repayment by end of 2025.
- Operational scalability allows margin improvement without new hires.
- Management confident in cash flow positive trajectory.
Challenges Ahead
- Product division margin declined from 50% to 44% YoY.
- Adjusted EBITDA still negative despite improvements.
- Gross margin gains in products offset by facility expansion costs.
- Higher depreciation from new equipment reduces net margin.
- No guidance provided on full-year EPS or revenue targets.